Hong Mu-Mosley1, Mitchell S von Itzstein1,2, Farjana Fattah1

  • 1Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.

Oncoimmunology
|May 13, 2024
PubMed
概括

免疫检查点抑制剂 (ICI) 对自身抗体水平的影响不同. 含有ipilimumab的疗法增加了自身抗体,而nivolumab则降低了自身抗体,根据免疫相关的不良事件而有所变化.